I SINGH, V CHEONG, S GAN, TJ KHOO AND AP MORRIS, 2010. Refined Palm Oil’s Potential as Transdermal Drug Delivery Enhancer Medical Journal of Malaysia. 65(A), 99 (In Press.)
HF KWOK, C IVANYI, AP MORRIS AND C SHAW, 2010. Proteomic and Genomic Studies on Lizard Venoms in the Last Decade Proteomics Insights. 3, 25-31 (In Press.)
I SINGH, V CHEONG, S GAN, TJ KHOO and A MORRIS, 2010. Transdermal Permeation: Refined Palm Oil Vehicle Effects? In: 11th Annual Skin Forum Meeting, Edinburgh, UK.
I SINGH, V CHEONG, S GAN, TJ KHOO and A MORRIS, 2010. Liquid paraffin status in transdermal drug delivery In: 23rd Federation of Asian Pharmaceutical Associations (FAPA) Congress 2010, Taipei, Taiwan.
S PRASANTHI, S INDERJEET, V CHEONG, AP MORRIS AND SY GAN, 2009. Percutaneous permeation of triacylglycerols, tocols and beta-carotene from palm oil In: Palm International Nutra-Cosmeceutical Conference. Kuala Lumpur, Malaysia. (In Press.)
MORRIS, AP, BRAIN, KR and HEARD, CM, 2009. Skin Permeation And Ex Vivo Skin Metabolism Of O-Acyl Haloperidol Ester Prodrugs International Journal Of Pharmaceutics. 367(1-2), 44-50 S PRASANTHI, S GAN, VS CHRISTINA AND AP MORRIS, 2008. Percutaneous permeation of palm oil: maintenance of sink conditions In: Malaysian Pharmaceutical Society Pharmacy Scientific Conference [Oral presentation], Kuantan, Malaysia. (In Press.)
SW TAN, N BILLA, AP MORRIS AND T JULIANTO, 2008. Preliminary characterization studies on lipid nanoparticular dispersion of amphotericin B. In: Malaysian Pharmaceutical Society Pharmacy Scientific Conference [Oral presentation], Kuantan, Malaysia.. (In Press.)
SW TAN, N BILLA, AP MORRIS AND T JULIANTO, 2008. Effect of surfactant combination on stability of lipid nanoparticles In: 22th Congress of Federation of Asian Pharmaceutical Association (FAPA), Singapore. (In Press.)
AP MORRIS, 2006. Community Pharmacy & Clinical Governance: a Snapshot from the UK In: Malaysian Pharmaceutical Society Pharmacy Scientific Conference [Oral presentation], Kuala Lumpur, Malaysia.. (In Press.)
AP MORRIS, 2005. Pharmacist Interventions in Merthyr Tydfil In: LPC Annual Conference. London, UK.. (In Press.)
CHILCOTT, RP, BARAI, N, BEEZER, AE, BRAIN, SI, BROWN, MB, BUNGE, AL, BURGESS, SE, CROSS, S, DALTON, CH, DIAS, M, FARINHA, A, FINNIN, BC, GALLAGHER, SJ, GREEN, DM, GUNT, H, GWYTHER, RL, HEARD, CM, JARVIS, CA, KAMIYAMA, F, KASTING, GB, LEY, EE, LIM, ST, MCNAUGHTON, GS, MORRIS, A, NAZEMI, MH, PELLETT, MA, DU PLESSIS, J, QUAN, YS, RAGHAVAN, SL, ROBERTS, M, ROMONCHUK, W, ROPER, CS, SCHENK, D, SIMONSEN, L, SIMPSON, A, TRAVERSA, BD, TROTTET, L, WATKINSON, A, WILKINSON, SC, WILLIAMS, FM, YAMAMOTO, A and HADGRAFT, J, 2005. Inter- And Intralaboratory Variation Of In Vitro Diffusion Cell Measurements: An International Multicenter Study Using Quasi-Standardized Methods And Materials Journal Of Pharmaceutical Sciences. 94(3), 632-638 AP MORRIS, KR BRAIN, CM HEARD, G MCNAUGHTON AND G STODDART., 2004. Rationalisation of Dermal Ester Prodrugs Using an Active Site Model Perspectives in Percutaneous Penetration. 9a(20), (In Press.)
AP MORRIS, 2004. New tool to assist clinical governance in Wales Pharmaceutical Journal. 273(7308), 98 (In Press.)
AP MORRIS, J PARKES, 2004. Pharmacy Involvement in Medicines Management Across Wales, Briefing Paper – Royal Pharmaceutical Society of Great Britain (In Press.)
AP MORRIS, 2004. Piloting the Clinical Governance Maturity Matrix™ In: British Pharmaceutical Conference [Invited Oral Presentation]. Manchester, UK. (In Press.)
AP MORRIS, KR BRAIN, CM HEARD,, 2003. Rationalising Haloperidol Prodrug Hydrolysis Using An Esterase Active Site Model In: 4th Annual Skin Forum Meeting, Newcastle, UK. (In Press.)
AP MORRIS, KR BRAIN AND CM HEARD, 2002. Comparison of the Flux of Haloperidol Through Full-Thickness Human Breast and Guinea Pig Skin in the Presence and Absence of the Surfactant Cetrimide Perspectives in Percutaneous Penetration. 8a, 28 (In Press.)
C SEARS, CM HEARD AND AP MORRIS., 2002. Transdermal Delivery of Extract of Hypericum Perforatum Perspectives in Percutaneous Penetration. 8a(95), (In Press.)
AP MORRIS, KR BRAIN AND CM HEARD, 2002. Percutaneous Permeation of Haloperidol Prodrugs, Rationally Designed Using Solubility Parameter Theory In: 3rd Annual Skin Forum Meeting, Guildford, UK.. (In Press.)
AP MORRIS, KR BRAIN AND CM HEARD, 2000. Potential of Haloperidol Prodrugs for Transdermal delivery Perspectives in Percutaneous Penetration. 7a(66), (In Press.)
CW JEANS, AP MORRIS, CJ ALLENDER, KR BRAIN AND CM HEARD, 2000. Primaquine is Emerging as a Potential Candidate for the Development of a Transdermal System for Combating Malaria Perspectives in Percutaneous Penetration. 7a(140), (In Press.)
AP MORRIS, WJ KEE, KR BRAIN, CM HEARD AND AC WATKINSON, 1998. Vehicle Effects In The Permeation Of Primaquine Across Human Skin in vitro Perspectives in Percutaneous Penetration. 5b, 180-182 (In Press.)